Literature DB >> 20410633

Characterization of structures and antiviral effects of polysaccharides from Portulaca oleracea L.

Cai-Xia Dong1, Kyoko Hayashi, Jung-Bum Lee, Toshimitsu Hayashi.   

Abstract

Three polysaccharides including a neutral polysaccharide (RN), an acidic polysaccharide (RA) and a pectic polysaccharide (RP) were isolated from aerial part of Portulaca oleracea L. and evaluated for their anti-herpes simplex virus type 2 (HSV-2) and anti-influenza A virus (IFV-A). RN was found to consist of glucose (Glc), mannose (Man) and arabinose (Ara) with small amounts of galactose (Gal), and identified to be an arabinoglucomannan. RA was mainly composed of Gal and Ara with a small proportion of glucuronic acid (GlcA). It was characterized as a type II arabinogalactan (AGII), which consisted of a 1,3-, 1,6- and 1,3,6-linked galactopyranosyl (Galp) and non-reducing terminal and 1,5-linked arabinofuranosyl (Araf) residues. RP was deduced to be a pectin, which consisted of a predominant amount of galacturonic acid (GalA) with small amounts of Gal, rhamnose (Rha) and Ara. The GalA residues were found to be highly methyl-esterified and partially acetylated. Results of antiviral tests showed that only RP had anti-HSV-2 activity. Furthermore, its anti-HSV-2 target was elucidated to be the step of virus penetration into host cells. No marked virucidal activity of RP was observed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410633     DOI: 10.1248/cpb.58.507

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  14 in total

1.  Inhibition of Murine Norovirus and Feline Calicivirus by Edible Herbal Extracts.

Authors:  Dong Joo Seo; Changsun Choi
Journal:  Food Environ Virol       Date:  2016-11-02       Impact factor: 2.778

2.  Synthesis and biological evaluation of biotin-conjugated Portulaca oleracea polysaccharides.

Authors:  Qianqian Han; Lirong Huang; Qiang Luo; Ying Wang; Mingliang Wu; Shixin Sun; Hongmei Zhang; Yanqing Wang
Journal:  RSC Adv       Date:  2021-05-19       Impact factor: 4.036

3.  Alternative Strategies in Response to Saline Stress in Two Varieties of Portulaca oleracea (Purslane).

Authors:  Kristina R Mulry; Bryan A Hanson; Dana A Dudle
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

Review 4.  Portulaca oleracea L.: a review of phytochemistry and pharmacological effects.

Authors:  Yan-Xi Zhou; Hai-Liang Xin; Khalid Rahman; Su-Juan Wang; Cheng Peng; Hong Zhang
Journal:  Biomed Res Int       Date:  2015-01-26       Impact factor: 3.411

5.  Antioxidant and Antiproliferative Activities of Purslane Seed Oil.

Authors:  Gai Guo; Li Yue; Shaoli Fan; Siqun Jing; Liang-Jun Yan
Journal:  J Hypertens (Los Angel)       Date:  2016-04-25

Review 6.  A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients.

Authors:  Ipsita Kumar Sen; Indranil Chakraborty; Amit Kumar Mandal; Sunil Kumar Bhanja; Sukesh Patra; Prasenjit Maity
Journal:  Int J Biol Macromol       Date:  2021-03-29       Impact factor: 8.025

7.  Effervescent Granules Prepared Using Eucommia ulmoides Oliv. and Moso Bamboo Leaves: Hypoglycemic Activity in HepG2 Cells.

Authors:  Xiang-Zhou Li; Sheng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-28       Impact factor: 2.629

Review 8.  Natural Products-Derived Chemicals: Breaking Barriers to Novel Anti-HSV Drug Development.

Authors:  Jakub Treml; Markéta Gazdová; Karel Šmejkal; Miroslava Šudomová; Peter Kubatka; Sherif T S Hassan
Journal:  Viruses       Date:  2020-01-29       Impact factor: 5.048

9.  Anti-Viral Activity of Indian Plants.

Authors:  B N Dhawan
Journal:  Proc Natl Acad Sci India Sect B Biol Sci       Date:  2012-01-18

Review 10.  A Comprehensive Review on Chemotaxonomic and Phytochemical Aspects of Homoisoflavonoids, as Rare Flavonoid Derivatives.

Authors:  Javad Mottaghipisheh; Hermann Stuppner
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.